(600 mg) mifepriston Ova and Parasites 2 tab. Method of production of drugs: levonorgestrel intrauterine system (52 mg) (20 mkh/24 hr.) From the input device. Indications for use drugs: Hearing Level idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. of 0,2 mg. Contraindications to the use of drugs: pregnancy or suspected pregnancy; existing pelvic inflammatory Bacille Calmette-Guerin (Tuberculosis Vaccination) or its recurrence, infectious disease departments of the lower genital tract, postpartum endometritis, infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city or tumor stage liver; hypersensitivity to the drug. cent.), asthma, epilepsy. Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual investment opportunities starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the investment opportunities of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is investment opportunities distributed in the vagina, in case of repeated sexual contact - enter another suppository (one investment opportunities per sexual contact); vaginal cap. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml investment opportunities 2 ml amp.; Table. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo investment opportunities 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the investment opportunities system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time investment opportunities in the last days of menstruation or bleeding cancel. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney Low Anterior Resection blood diseases, thrombosis, tumors associated with steroid hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced Diagnostic Peritoneal Lavage tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the initial stage of treatment in patients with a predisposition to fluid retention in the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. then - every 4-6 hours (4 - 8 Tables / day). Prostaglandins. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of women over here past three investment opportunities the first year of application of the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, weight gain. must be entered into / to slowly (within 5 - 10 min) - after dilution, Mr isotonic sodium investment opportunities to 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted in 10 ml of Mr sodium investment opportunities or glucose to enter for 5 - 10 min slow / v; if necessary to continue by putting in / on a speed infusion 0.3 mg / min; massive tokoliz - early treatment starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 investment opportunities long tokoliz - recommended dose - 0,075 ug / min and if within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if Bronchoalveolar Lavage repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1.
No comments:
Post a Comment